Skip to main content
TipRanks
Go Ultimate75% OFF

Alar Pharmaceuticals Inc (6785) Q4 2022 Earnings Report

TW:6785 Q4 2022 EPS Results

Actual EPS
-TWD 0.14
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-TWD 1.00

TW:6785 Q4 2022 Revenue Results

Actual Revenue
TWD 800.00K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2022
Date
02/22/2023
Time
Before Open
Conference Call
Wednesday, February 22, 2023
TW:6785 Upcoming Earnings

Alar Pharmaceuticals Inc's next earnings date is estimated for March 9, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:6785 Earnings History

TW:6785 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 09, 20272026 (Q4)―--0.38――
Nov 05, 20262026 (Q3)―--0.41―
Aug 06, 20262026 (Q2)―0.23-0.38162.13% (+0.61)
May 07, 20262026 (Q1)―-0.53-0.03-1600.00% (-0.50)
Mar 03, 20262025 (Q4)―-0.380.37-202.42% (-0.75)
Nov 06, 20252025 (Q3)―-0.41-0.23-78.07% (-0.18)
Aug 07, 20252025 (Q2)―-0.38-0.05-607.55% (-0.32)
May 08, 20252025 (Q1)―-0.030.18-117.22% (-0.21)
Mar 04, 20252024 (Q4)―0.377.15-94.80% (-6.78)
Nov 07, 20242024 (Q3)-0.19-0.230.03-860.00% (-0.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed